Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay

Journal of Clinical Virology

Volumn 44, Issue 1, 2009, Pages 9-14

  Maple, P A C ^a   Rathod, P ^b   Smit, E ^b   Gray, J ^a   Brown, D ^a   Boxall, E H ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b West Midlands Training Scheme   (United Kingdom)

Author keywords

Dose response curves; Time resolved fluorescence immunoassay; Varicella Zoster; VZV LIAISON and VIDAS assays

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; CHICKENPOX; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOPROPHYLAXIS; INFECTION RISK; INTERMETHOD COMPARISON; PREGNANCY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TIME RESOLVED FLUORESCENCE IMMUNOASSAY; VARICELLA ZOSTER VIRUS; VIRUS DIAGNOSIS;

ANTIBODIES, VIRAL; CHICKENPOX; FEMALE; FLUORESCENCE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 57749103994     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.08.012     Document Type: Article

References (14)

1. Srabstein J.C., Morris N., Larke R.P.B., deSa D.J., Castelino B.B., and Sum E. Is there a congenital varicella syndrome?. J Pediatr 84 (1974) 239-243
2. Enders G., Miller E., Cradock-Watson J., Bolley I., and Ridehaigh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343 (1994) 1548-1551
3. Alkalay A.L., Pomerance J.J., and Rimoin D.L. Fetal varicella syndrome. J Pediatr 111 (1987) 320-323
4. Enders G., and Miller E. Varicella and herpes zoster in pregnancy and the newborn. In: Arvin A.M., and Gershon A.A. (Eds). Varicella-zoster virus (2000), Cambridge University Press, Cambridge
5. Joint Committee of Vaccination and Immunisation. Immunisation against infectious disease. Department of Health; 2006.
6. Steinberg S.P., and Gershon A.A. Measurement of antibodies to Varicella-Zoster virus by using a latex agglutination test. J Clin Microbiol 29 (1991) 1527-1529
7. Grandien M., Appelgren P., Espmark A., and Hanngren K. Determination of varicella immunity by the indirect immunofluorescence test in urgent clinical situations. Scand J Infect Dis 8 (1976) 65-69
8. Wreghitt T.G., Tedder R.S., Nagington J., and Ferns R.B. Antibody assays for Varicella-Zoster virus. Comparison of competitive enzyme-linked immunosorbent assay (ELISA), competitive radioimmunoassay (RIA), complement fixation and indirect immunofluorescence assays. J Med Virol 13 (1984) 361-370
9. Shanley J., Myers M., Edmond B., and Steele R. Enzyme-linked immunosorbent assay for detection of antibody to Varicella Zoster virus. J Clin Microbiol 15 (1982) 208-211
10. Maple P.A.C., Gray J., Breuer J., Kafatos G., Parker S., and Brown D. Performance of a time resolved fluorescence immunoassay for measuring varicella zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin Vaccine Immunol 13 (2006) 214-218
11. Robert Koch-Institut. Mitteilung der Standigen impfkommission (STIKO) am Robert Koch-Institut. Fragen und Antworten zu verschiedenen Impfungen. Epidemiol Bull 2001;8:58.
12. Gleaves C.A., Schwarz K.A., and Campbell M.B. Determination of Varicella-Zoster virus (VZV) immune status with the VIDAS VZV immunoglobulin G automated immunoassay and the VZVScan latex agglutination assay. Clin Vaccine Immunol 3 (1996) 365-367
13. Maple, et al., in preparation.
14. Sauerbrei A., Farber I., Brandstadt A., Schacke M., and Wutzler P. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test. J Virol Meth 119 (2004) 25-30